lobbying_activities: 1694975

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1694975	1e01578b-9db5-44d9-ba7d-a45c7801b700	Q2	BROWN RUDNICK LLP	287895	AMNEAL PHARMACEUTICALS	2015	second_quarter	PHA	Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2015-07-14T15:07:47.183000-04:00